CPIX

News Cumberland outlines $100M Apotex deal while shifting to development-focused strategy

27d ago

SEC filing CPIX Reports $9.1M Q1 Rev, $3.3M Net Loss, $100M Apotex Deal, Ifetroban Fast Track DMD, Phase II SSc, IPF Enrollment

28d ago

SEC filing CPIX Announces $100M Apotex Deal, Retains Ifetroban Pipeline, Orphan Drug Designations, Phase II Results Pending

40d ago

News Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion

90d ago

News RedHill Biopharma Receives Nasdaq Staff Determination Notification

153d ago

Scanner Unusual volume (z=9.8)

168d ago